Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-29 3:04 pm Purchase | 2024-11-14 | 13D | Chemomab Therapeutics Ltd. CMMB | Mor George Adi | 898,221 4.800% | 150,776 (+20.17%) | Filing History |
| 2024-11-21 10:59 am Purchase | 2024-11-21 | 13G | Chemomab Therapeutics Ltd. CMMB | Otto Erik | 1,155,000 6.100% | 1,155,000 (New Position) | Filing History |
| 2024-09-16 4:34 pm Sale | 2024-09-12 | 13D | Chemomab Therapeutics Ltd. CMMB | OrbiMed Israel BioFund GP Limited Partnership | 1,860,906 9.990% | -409,185 (-18.03%) | Filing History |
| 2024-08-20 2:36 pm Purchase | 2024-07-25 | 13G | Chemomab Therapeutics Ltd. CMMB | SPHERA FUNDS MANAGEMENT LTD. | 1,214,575 6.560% | 1,214,575 (New Position) | Filing History |
| 2024-03-11 7:19 pm Unchanged | 2024-03-11 | 13D | Chemomab Therapeutics Ltd. CMMB | OrbiMed Israel BioFund GP Limited Partnership | 2,270,091 16.000% | 0 (Unchanged) | Filing History |
| 2023-11-15 4:35 pm Unchanged | 2023-11-14 | 13D | Chemomab Therapeutics Ltd. CMMB | OrbiMed Israel BioFund GP Limited Partnership | 2,270,091 18.300% | 0 (Unchanged) | Filing History |
| 2023-01-05 4:31 pm Sale | 2023-01-03 | 13D | Chemomab Therapeutics Ltd. CMMB | OrbiMed Israel BioFund GP Limited Partnership | 2,270,091 19.700% | -49,869,729 (-95.65%) | Filing History |
| 2022-11-17 4:40 pm Sale | 2022-11-16 | 13D | Chemomab Therapeutics Ltd. CMMB | Mor George Adi | 747,445 6.400% | -582,023 (-43.78%) | Filing History |
| 2022-02-10 4:02 pm Purchase | 2021-12-31 | 13G | Chemomab Therapeutics Ltd. CMMB | Gabriel Capital Management Ltd. | 3,087,040 1.400% | 3,087,040 (New Position) | Filing History |
| 2022-01-20 06:01 am Purchase | 2021-03-16 | 13D | Chemomab Therapeutics Ltd. CMMB | Mor George Adi | 1,329,468 11.500% | 1,329,468 (New Position) | Filing History |
| 2021-04-15 5:28 pm Purchase | 2021-03-16 | 13D | Chemomab Therapeutics Ltd. CMMB | Access Industries Holdings LLC | 5,057,766 2.360% | 5,057,766 (New Position) | Filing History |
| 2021-03-26 4:06 pm Purchase | 2021-03-16 | 13D | Chemomab Therapeutics Ltd. CMMB | OrbiMed Israel BioFund GP Limited Partnership | 52,139,820 24.300% | 52,139,820 (New Position) | Filing History |
| 2021-03-26 08:10 am Purchase | 2021-03-16 | 13G | Chemomab Therapeutics Ltd. CMMB | THIEL PETER | 22,631,260 10.600% | 22,631,260 (New Position) | Filing History |
| 2020-12-21 4:31 pm Unchanged | 2020-12-14 | 13D | ANCHIANO THERAPEUTICS LTD ANCN | Access Industries Holdings LLC | 15,829,397 42.700% | 0 (Unchanged) | Filing History |
| 2020-12-17 5:36 pm Sale | 2020-12-17 | 13D | ANCHIANO THERAPEUTICS LTD ANCN | Palisade Medical Equity I LP | 0 0.000% | -1,848,200 (Position Closed) | Filing History |
| 2020-05-22 1:34 pm Purchase | 2019-05-21 | 13D | ANCHIANO THERAPEUTICS LTD ANCN | Palisade Medical Equity I LP | 1,848,200 4.980% | 1,848,200 (New Position) | Filing History |
| 2020-03-31 08:22 am Unchanged | 2020-03-30 | 13D | ANCHIANO THERAPEUTICS LTD ANCN | Access Industries Holdings LLC | 15,829,397 40.100% | 0 (Unchanged) | Filing History |